at Upcoming Conferences

(Adnkronos) – HOUSTON, Sept. 14, 2023 /PRNewswire/ — FibroBiologics, a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced today that Pete O’Heeron, Founder/Chief Executive Officer, and Hamid